Certara, Inc. (CERT)

NASDAQ

$8.76

+$0.18 (2.04%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$8.42$8.83

Open $8.72

52 Week Range

$8.03$15.69

Previous Close $8.58

Market Cap1.41B

Volume2.45M

Avg Volume2.12M

P/E (TTM)176.52

EPS (TTM)$0.05

Dividend / YieldN/A

Dividend StreakN/A

Latest Press Releases for Certara, Inc.

DEC112025

Certara Appoints Jon Resnick as Chief Executive Officer

Source: GlobeNewsWire•5 days ago

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial growth...

NOV62025

Certara Reports Third Quarter 2025 Financial Results

Source: GlobeNewsWire•39 days ago

RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal year 2025....

NOV42025

Certara Automates Scientific Workflows with Phoenix® Cloud

Source: GlobeNewsWire•41 days ago

RADNOR, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of TFL Studio, the first cloud-native module of its Phoenix Cloud solution....

OCT312025

Certara to Participate in Upcoming Investor Conferences

Source: GlobeNewsWire•45 days ago

RADNOR, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:...

OCT302025

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Source: GlobeNewsWire•46 days ago

RADNOR, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara IQ, a scalable, AI-powered Quantitative Systems Pharmacology (QSP) solution....

OCT202025

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Source: GlobeNewsWire•56 days ago

RADNOR, Pa., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced its continued influence in pharmaceutical research....

OCT102025

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Source: GlobeNewsWire•66 days ago

RADNOR, Pa., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of 2025 after the market close on Thursday, November 6th, 2025...